Page 5 - Oncomap Extra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analysts expect that Exact Sciences Co. (NASDAQ:EXAS – Get Rating) will post sales of $461.86 million for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Exact Sciences’ earnings, with estimates ranging from $458.10 million to $466.90 million. Exact Sciences reported sales of $402.08 million during the same quarter last year, […]

Analysts expect Exact Sciences Co. (NASDAQ:EXAS – Get Rating) to announce ($1.12) earnings per share for the current quarter, according to Zacks. Seven analysts have issued estimates for Exact Sciences’ earnings, with the highest EPS estimate coming in at ($0.98) and the lowest estimate coming in at ($1.22). Exact Sciences posted earnings of ($0.18) per […]